Cytta Corp. restates Dec 2024 financials; revenue overstated by $37K from unverified sales orders

This filing

The Board of Directors of Cytta Corp. has now concluded, after investigation, that the interim financial statements included in the December 31, 2024 Form 10-Q should no longer be relied upon because of an error in revenue recognition.

Comparable filing

On June 1, 2026, the audit committee of the Company, after considering the recommendations of management, concluded that the Company’s previously issued unaudited consolidated financial statements contained within its (i) Quarterly Report on Form 10-Q as of March 31, 2025 and for the three months then ended, filed with the Securities and Exchange Commission (“SEC”) on May 20, 2025, (ii) Quarterly Report on Form 10-Q as of June 30, 2025 and for the three and six months then ended, filed with the SEC on August 14, 2025, and (iii) Quarterly Report on Form 10-Q as of September 30, 2025 and for the three and nine months then ended, filed with the SEC on November 17, 2025 should no longer be relied due the 2025 Financial Statement Errors.

This filing

The Board of Directors of Cytta Corp. has now concluded, after investigation, that the interim financial statements included in the December 31, 2024 Form 10-Q should no longer be relied upon because of an error in revenue recognition.

Comparable filing

the Company’s independent registered public accounting firm, Michael Gillsepie & Associates, PLLC (“Gillespie & Associates”), notified the Company that the Company did not follow US GAAP because an invoice dated September 23, 2025, from the Company’s legal counsel in the amount of $9,840 to the Company, which covered legal services rendered to the Company between May 21, 2024 and September 23, 2025, should have been recorded in the fiscal quarters when services were performed

This filing

The Board of Directors of Cytta Corp. has now concluded, after investigation, that the interim financial statements included in the December 31, 2024 Form 10-Q should no longer be relied upon because of an error in revenue recognition.

Comparable filing

On May 21, 2026, the Audit Committee (the “Audit Committee”) of the Board of Directors of NeuroOne Medical Technologies Corporation (the “Company”), after discussion with management, determined that the Company’s previously issued interim financial statements included in the Company’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2026, filed on May 12, 2026 (the “Previous Filing”), should no longer be relied upon and should be restated because of accounting errors relating to revenue recognition.

This filing

The Board of Directors of Cytta Corp. has now concluded, after investigation, that the interim financial statements included in the December 31, 2024 Form 10-Q should no longer be relied upon because of an error in revenue recognition.

Comparable filing

On May 5, 2026, the management of BestGofer, Inc. (the “Company”), in connection with the determination of a material non-cash impairment charge for the goodwill associated with the Company’s wholly-owned subsidiary, Liberty Home Inspection Services LLC (“LHIS”), concluded that the Company’s previously issued unaudited interim financial statements for the three months ended February 28, 2026, as filed with the Securities and Exchange Commission (the “SEC”) on April 22, 2026 in the Company’s Quarterly Report on Form 10-Q (SEC Accession No. 0001722556-26-000016) (the “Original Form 10-Q”), should no longer be relied upon.

This filing

The Board of Directors of Cytta Corp. has now concluded, after investigation, that the interim financial statements included in the December 31, 2024 Form 10-Q should no longer be relied upon because of an error in revenue recognition.

Comparable filing

the audit committee of the board of directors of the Company (the “Audit Committee”) was made aware of and, after discussion with senior management of the Company, concluded that the Company’s previously issued (i) audited consolidated financial statements for the fiscal year ended March 31, 2024, included in the Company’s Annual Report on Form 10-K for such fiscal year (the “2024 10-K”), (ii) audited consolidated financial statements for the fiscal year ended March 31, 2025, included in the Company’s Annual Report on Form 10-K for such fiscal year (the “2025 10-K”) and (iii) unaudited consolidated financial statements for the quarterly periods ended September 30, 2023, December 31, 2023, June 30, 2024, September 30, 2024, December 31, 2024, June 30, 2025, September 30, 2025, and December 31, 2025, included in the Company’s Quarterly Reports on Form 10-Q for such quarterly periods (collectively, the “Prior Financial Statements”), should no longer be relied upon

This filing

The Board of Directors of Cytta Corp. has now concluded, after investigation, that the interim financial statements included in the December 31, 2024 Form 10-Q should no longer be relied upon because of an error in revenue recognition.

Comparable filing

On April 9, 2026, the management of PreAxia Health care Payment Systems Inc., a Nevada corporation (the “Company”), identified material errors in the previously released financial statements for the three months ended August 31, 2025 (the “Non-Reliance Period”) and concluded that such financial statements should no longer be relied upon.

This filing

The Board of Directors of Cytta Corp. has now concluded, after investigation, that the interim financial statements included in the December 31, 2024 Form 10-Q should no longer be relied upon because of an error in revenue recognition.

Comparable filing

On April 11, 2026, the audit committee (the “Audit Committee”) of the board of directors of Rain Enhancement Technologies Holdco, Inc., a Massachusetts corporation (the “Company”), in consultation with management, determined that the Company’s previously issued unaudited condensed consolidated financial statements contained in its (i) Quarterly Report on Form 10-Q as of and for the three months ended March 31, 2025, filed with the Securities and Exchange Commission (“SEC”) on May 15, 2025 and (ii) Quarterly Report on Form 10-Q as of and for the three and six months ended June 30, 2025, filed with the SEC on August 14, 2025 (the “Affected Periods”), should no longer be relied upon due to an error in the accounting for financed insurance premiums.

This filing

The Board of Directors of Cytta Corp. has now concluded, after investigation, that the interim financial statements included in the December 31, 2024 Form 10-Q should no longer be relied upon because of an error in revenue recognition.

Comparable filing

On March 18, 2026, the Chief Financial Officer of Solidion Technology, Inc. (the “Company”), after consultation with the Company’s Audit Committee, concluded that the Company’s previously issued audited financial statements as of and for the year ended December 31, 2024 and related audit report as well as the interim periods within that year (the “Affected Financial Information”), included in the Company’s Annual Report on Form 10-K for such period, should no longer be relied upon.